Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main objective of the study is to assess the feasibility, safety, and tolerability of the administration of HCR040, a drug whose active substance is HC016, allogeneic adipose-derived adult mesenchymal stem cells expanded and pulsed with H2O2, in patients with acute respiratory distress syndrome.
Epistemonikos ID: dbfbc5847fe33df103dbc69e098b985165e6d2ec
First added on: May 07, 2024